Churchill, M <br/><br/>
Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile.  [electronic resource] 

 -  The Journal of surgical research  Apr 2000 
 - 169-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-4804 
<br/><br/><label>Standard No.: </label>10.1006/jsre.2000.5826  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenomatous Polyposis Coli Protein<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>B-Lymphocytes--drug effects<br/>CD4 Lymphocyte Count--drug effects<br/>CD4-Positive T-Lymphocytes--pathology<br/>Curcumin--pharmacology<br/>Cytoskeletal Proteins--genetics<br/>Germ-Line Mutation<br/>Immune System--cytology<br/>Immunohistochemistry<br/>Intestinal Mucosa--drug effects<br/>Intestinal Neoplasms--genetics<br/>Intestines--cytology<br/>Lymphocyte Count--drug effects<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Mutant Strains--genetics